Rx for Biotech
Podcast Host Chris Leidli
Add to My Podcasts
Episodes
About
Reviews
Promote
Harnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
39 minutes
Posted Aug 21, 2025 at 4:54 pm.
0:00
39:43
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining immunotherapy with its proprietary Versamune® T-cell activating platform.
Previous
How Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
Next
The Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies
← See all 74 episodes of Rx for Biotech